These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6776756)

  • 1. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly.
    Hanew K; Sasaki A; Mouri T; Yoshinaga K
    Acta Endocrinol (Copenh); 1980 Nov; 95(3):298-307. PubMed ID: 6776756
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
    Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC
    Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
    Hanew K; Aida M; Sasaki A; Mouri T; Yoshinaga K
    Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Response of growth hormone to sandostatin and bromocriptine and prognostic value of prolactin levels in serum and thyroliberin test in patients with active acromegaly].
    Gasińska T; Nowak S
    Endokrynol Pol; 1993; 44(4):455-65. PubMed ID: 8055814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term bromocriptine therapy and predictive tests in acromegaly.
    Karashima T; Kato K; Nawata H; Ikuyama S; Ibayashi H; Okamura K; Shiroozu A; Nakashima T; Fujishima M
    Endocrinol Jpn; 1986 Apr; 33(2):163-7. PubMed ID: 3093202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
    Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
    Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of effect of thyroid hormones on the growth hormone response to thyrotropin-releasing hormone in acromegaly.
    Carlson HE; Sowers JR; Rand RW
    Metabolism; 1977 Jul; 26(7):801-5. PubMed ID: 405552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.
    Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
    Acta Endocrinol (Copenh); 1987 Sep; 116(1):53-8. PubMed ID: 2889308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly.
    Hanew K; Sugawara A; Shimizu Y; Sato S; Sasaki A; Tazawa S; Ishii K; Saitoh T; Saso S; Yoshinaga K
    Endocrinol Jpn; 1989 Jun; 36(3):429-38. PubMed ID: 2510991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors determining the effectiveness of CB-154 in the treatment of acromegaly.
    Hanew K; Sasaki A; Sato S; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1983 Jan; 139(1):91-5. PubMed ID: 6404005
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine therapy in acromegaly: use in patients resistant to conventional therapy and effect on serum levels of somatomedin C.
    Moses AC; Molitch ME; Sawin CT; Jackson IM; Biller BJ; Furlanetto R; Reichlin S
    J Clin Endocrinol Metab; 1981 Oct; 53(4):752-8. PubMed ID: 6793607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
    Felt V; Nedvídková J
    Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly.
    Roelfsema F; Goslings BM; Frölich M; Moolenaar AJ; Seters AP; Van Slooten H
    Clin Endocrinol (Oxf); 1979; 11(2):235-44. PubMed ID: 114344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
    Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
    J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum growth hormone and prolactin response to thyrotropin-releasing hormone in patients with acromegaly before and after surgery.
    Samaan NA; Leavens ME; Jesse RH
    J Clin Endocrinol Metab; 1974 Jun; 38(6):957-63. PubMed ID: 4208807
    [No Abstract]   [Full Text] [Related]  

  • 20. [Growth hormone secretion in relation to changes in thyrotropic hormone after thyroliberin in patients with acromegaly and dopaminergic stimulation (author's transl)].
    Felt V; Nedvídková J
    Cas Lek Cesk; 1982 Apr; 121(16):489-93. PubMed ID: 6807547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.